Nakazone Marcelo Arruda, Machado Maurício Nassau, Otaviano Ana Paula, Rodrigues Ana Maria Silveira, Cardinalli-Neto Augusto, Bestetti Reinaldo Bulgarelli
Postgraduate Division, São José do Rio Preto Medical School, 5416 Brigadeiro Faria Lima Ave., CEP 15090-000, São José do Rio Preto, Brazil.
Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto, 5544 Brigadeiro Faria Lima Ave., CEP 15090-000, São José do Rio Preto, Brazil.
Cardiol Res Pract. 2020 Jul 6;2020:6417874. doi: 10.1155/2020/6417874. eCollection 2020.
Few studies regarding chronic kidney disease (CKD) and anemia have been conducted in patients with Chagas cardiomyopathy (CC). We evaluated the risk prediction performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and anemia in CC patients.
From 2000 to 2010, a total of 232 patients were studied in a single-center retrospective study. CKD was defined as creatinine clearance <60 mL/min/1.73 m according to CKD-EPI equation. Anemia was defined as hemoglobin <12 g/dL (women) and <13 g/dL (men). Cox proportional hazards models were used to establish predictors for death.
At baseline, 98 individuals (42.2%) had criteria for CKD and 41 (17.7%) for anemia. During follow-up, 136 patients (58.6%) died. Independently, CKD and anemia were not associated with all-cause mortality. However, when they coexisted, an additional risk was attributed for these patients. Cox proportional hazard models analysis identified systolic blood pressure (hazard ratio, 0.99; 95% confidence interval (CI), 0.98 to 1.00; =0.015), implantable cardioverter-defibrillator (hazard ratio, 0.48; 95% CI, 0.27 to 0.85; =0.012), left anterior fascicular block (hazard ratio, 1.52; 95% CI, 1.08 to 2.13; =0.017), left ventricular end-diastolic diameter (hazard ratio, 1.04; 95% CI, 1.02 to 1.06; < 0.001), and serum sodium (hazard ratio, 0.95; 95% CI, 0.92 to 0.99; =0.020) as independent predictors for death.
CKD and anemia are not independent predictors for long-term mortality in CC patients. However, the prognosis is poorer in individuals with both comorbidities.
关于恰加斯心肌病(CC)患者慢性肾脏病(CKD)和贫血的研究较少。我们评估了慢性肾脏病流行病学协作组(CKD-EPI)方程和贫血对CC患者的风险预测性能。
在一项单中心回顾性研究中,对2000年至2010年期间的232例患者进行了研究。根据CKD-EPI方程,CKD定义为肌酐清除率<60 mL/min/1.73 m²。贫血定义为血红蛋白<12 g/dL(女性)和<13 g/dL(男性)。采用Cox比例风险模型建立死亡预测因子。
在基线时,98例个体(42.2%)符合CKD标准,41例(17.7%)符合贫血标准。在随访期间,136例患者(58.6%)死亡。单独来看,CKD和贫血与全因死亡率无关。然而,当它们同时存在时,这些患者会有额外的风险。Cox比例风险模型分析确定收缩压(风险比,0.99;95%置信区间[CI],0.98至1.00;P = 0.015)、植入式心脏复律除颤器(风险比,0.48;95% CI,0.27至0.85;P = 0.012)、左前分支阻滞(风险比,1.52;95% CI,1.08至2.13;P = 0.017)、左心室舒张末期直径(风险比,1.04;95% CI,1.02至1.06;P < 0.001)和血清钠(风险比;0.95;95% CI,0.92至0.99;P = 0.020)为死亡的独立预测因子。
CKD和贫血不是CC患者长期死亡率的独立预测因子。然而,两种合并症患者的预后较差。